Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Shire Pharmaceuticals Limited
Hampshire International Business Park, Chineham, Basingstoke, Hampshire , RG24 8EP
Telephone: +44 (0)1256 894 000
WWW: http://www.shire.com
Medical Information Direct Line: 0800 055 6614
Medical Information e-mail: medinfoUK@shire.com
Customer Care direct line: +44 (0)1256 894 107

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 07/10/2011
PIL Equasym XL 10 mg, 20 mg or 30 mg Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 24/06/2011 and displayed until 07/10/2011
Reasons for adding or updating:
  • Change to instructions about overdose
Updated on 14/02/2011 and displayed until 24/06/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to storage instructions
Updated on 24/11/2010 and displayed until 14/02/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to information for healthcare professionals
  • Change due to harmonisation of PIL.
  • Change of trade or generic name
  • Change to how the medicine works
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about missed dose
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
  • Change to information about drinking alcohol
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Extra statutory information
Updated on 17/08/2009 and displayed until 24/11/2010
Reasons for adding or updating:
  • Change of manufacturer
  • Change to Marketing Authorisation Holder
Updated on 03/11/2008 and displayed until 17/08/2009
Reasons for adding or updating:
  • Change to manufacturer contact details
  • Transfer of Marketing Authorisation Holder
Updated on 20/07/2006 and displayed until 03/11/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about missed dose
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to how the medicine works
  • Change to Further Information section
Updated on 12/07/2005 and displayed until 20/07/2006
Reasons for adding or updating:
  • Company name change or merger
  • Change to date of revision
Updated on 21/02/2005 and displayed until 12/07/2005
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  methylphenidate hydrochloride